2656 — 160 Health International Cashflow Statement
0.000.00%
Last trade - 00:00- HK$27.67bn
- HK$27.74bn
- CNY620.68m
Annual cashflow statement for 160 Health International, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -119 | -111 | -107 |
| Depreciation | |||
| Amortisation | |||
| Non-Cash Items | 53.5 | 65.7 | 70.6 |
| Discontinued Operations | |||
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | 11.6 | -31.1 | -30.5 |
| Change in Accounts Receivable | |||
| Change in Inventories | |||
| Change in Prepaid Expenses | |||
| Change in Accounts Payable | |||
| Change in Accrued Expenses | |||
| Change in Other Liabilities | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | -42.4 | -64.5 | -56 |
| Capital Expenditures | -2.49 | -2.78 | -0.942 |
| Purchase of Fixed Assets | |||
| Purchase / Acquisition of Intangibles | |||
| Other Investing Cash Flow Items | 5.76 | 5.47 | -11.9 |
| Sale of Business | |||
| Sale of Fixed Assets | |||
| Sale/Maturity of Investment | |||
| Purchase of Investments | |||
| Other Investing Cash Flow | |||
| Cash from Investing Activities | 3.27 | 2.69 | -12.8 |
| Financing Cash Flow Items | 17.1 | 100 | -2.75 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | -11.2 | 80.6 | 69.6 |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | -50.4 | 18.5 | 0.711 |